Autor: "Garcia-Closas, Montserrat" - OpacWWW

Skocz do pozycji: 1.

Tytuł:: Increase in power by obtaining 10 or more controls per case when type-1 error is small in large-scale association studies.
Autorzy:: Katki HA; Division of Cancer Epidemiology and Genetics, Department of Health and Human Services, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA. .
Berndt SI; Division of Cancer Epidemiology and Genetics, Department of Health and Human Services, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Machiela MJ; Division of Cancer Epidemiology and Genetics, Department of Health and Human Services, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Stewart DR; Division of Cancer Epidemiology and Genetics, Department of Health and Human Services, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Garcia-Closas M; Division of Cancer Epidemiology and Genetics, Department of Health and Human Services, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Kim J; Division of Cancer Epidemiology and Genetics, Department of Health and Human Services, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Shi J; Division of Cancer Epidemiology and Genetics, Department of Health and Human Services, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Yu K; Division of Cancer Epidemiology and Genetics, Department of Health and Human Services, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Rothman N; Division of Cancer Epidemiology and Genetics, Department of Health and Human Services, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.; Pokaż więcej
Źródło:: BMC medical research methodology [BMC Med Res Methodol] 2023 Jun 29; Vol. 23 (1), pp. 153. Date of Electronic Publication: 2023 Jun 29.
Typ publikacji:: Journal Article; Research Support, N.I.H., Intramural; Research Support, N.I.H., Extramural
MeSH Terms:: Odds Ratio*
Control Groups*
Research Design*
Humans

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 2.

Tytuł:: Interpretable, non-mechanistic forecasting using empirical dynamic modeling and interactive visualization.
Autorzy:: Mason L; Queen's University Belfast, Belfast, United Kingdom.
Berrington de Gonzalez A; National Institutes of Health, Rockville, Maryland, United States of America.
Garcia-Closas M; National Institutes of Health, Rockville, Maryland, United States of America.
Chanock SJ; National Institutes of Health, Rockville, Maryland, United States of America.
Hicks B; Queen's University Belfast, Belfast, United Kingdom.
Almeida JS; National Institutes of Health, Rockville, Maryland, United States of America.; Pokaż więcej
Źródło:: PloS one [PLoS One] 2023 Apr 03; Vol. 18 (4), pp. e0277149. Date of Electronic Publication: 2023 Apr 03 (Print Publication: 2023).
Typ publikacji:: Journal Article

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 3.

Tytuł:: DNA methylation age in paired tumor and adjacent normal breast tissue in Chinese women with breast cancer.
Autorzy:: Koka H; Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, DHHS, Bethesda, MD, USA.
Bodelon C; Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, DHHS, Bethesda, MD, USA.
Horvath S; Department of Human Genetics, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA.; San Diego Institute of Science, Alto Labs, San Diego, CA, USA.
Lee PMY; The Jockey Club School of Public Health and Primary Care, The Chinese University of Hong Kong., Prince of Wales Hospital, Sha Tin, N.T., Hong Kong SAR, China.
Wang D; Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, DHHS, Bethesda, MD, USA.; Cancer Genomics Research Laboratory, Leidos Biomedical Research, Frederick National Laboratory for Cancer Research, Frederick, MD, USA.
Song L; Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, DHHS, Bethesda, MD, USA.; Cancer Genomics Research Laboratory, Leidos Biomedical Research, Frederick National Laboratory for Cancer Research, Frederick, MD, USA.
Zhang T; Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, DHHS, Bethesda, MD, USA.
Hurson AN; Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, DHHS, Bethesda, MD, USA.
Guida JL; Division of Cancer Control and Population Sciences, National Cancer Institute, NIH, DHHS, Bethesda, MD, USA.
Zhu B; Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, DHHS, Bethesda, MD, USA.
Bailey-Whyte M; Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, DHHS, Bethesda, MD, USA.; School of Medicine, University of Limerick, Limerick, Ireland.
Wang F; The Jockey Club School of Public Health and Primary Care, The Chinese University of Hong Kong., Prince of Wales Hospital, Sha Tin, N.T., Hong Kong SAR, China.
Wu C; Department of Pathology, North District Hospital, Hong Kong, China.
Tsang KH; Department of Pathology, Yan Chai Hospital, Hong Kong, China.
Tsoi YK; Department of Surgery, North District Hospital, Hong Kong, China.
Chan WC; Department of Surgery, North District Hospital, Hong Kong, China.
Law SH; Department of Surgery, North District Hospital, Hong Kong, China.
Hung RKW; Department of Surgery, North District Hospital, Hong Kong, China.
Tse GM; Department of Anatomical and Cellular Pathology, The Chinese University of Hong Kong, Hong Kong, China.
Yuen KK; Department of Pathology, North District Hospital, Hong Kong, China.
Karlins E; Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, DHHS, Bethesda, MD, USA.; Cancer Genomics Research Laboratory, Leidos Biomedical Research, Frederick National Laboratory for Cancer Research, Frederick, MD, USA.
Jones K; Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, DHHS, Bethesda, MD, USA.; Cancer Genomics Research Laboratory, Leidos Biomedical Research, Frederick National Laboratory for Cancer Research, Frederick, MD, USA.
Vogt A; Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, DHHS, Bethesda, MD, USA.; Cancer Genomics Research Laboratory, Leidos Biomedical Research, Frederick National Laboratory for Cancer Research, Frederick, MD, USA.
Zhu B; Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, DHHS, Bethesda, MD, USA.; Cancer Genomics Research Laboratory, Leidos Biomedical Research, Frederick National Laboratory for Cancer Research, Frederick, MD, USA.
Hutchinson A; Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, DHHS, Bethesda, MD, USA.; Cancer Genomics Research Laboratory, Leidos Biomedical Research, Frederick National Laboratory for Cancer Research, Frederick, MD, USA.
Hicks B; Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, DHHS, Bethesda, MD, USA.; Cancer Genomics Research Laboratory, Leidos Biomedical Research, Frederick National Laboratory for Cancer Research, Frederick, MD, USA.
Garcia-Closas M; Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, DHHS, Bethesda, MD, USA.
Chanock S; Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, DHHS, Bethesda, MD, USA.
Barnholtz-Sloan J; Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, DHHS, Bethesda, MD, USA.; Center for Biomedical Informatics and Information Technology, National Cancer Institute, NIH, DHHS, Bethesda, MD, USA.
Tse LA; The Jockey Club School of Public Health and Primary Care, The Chinese University of Hong Kong., Prince of Wales Hospital, Sha Tin, N.T., Hong Kong SAR, China. .
Yang XR; Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, DHHS, Bethesda, MD, USA. .; Pokaż więcej
Źródło:: Clinical epigenetics [Clin Epigenetics] 2023 Mar 30; Vol. 15 (1), pp. 55. Date of Electronic Publication: 2023 Mar 30.
Typ publikacji:: Journal Article; Research Support, N.I.H., Intramural; Research Support, Non-U.S. Gov't
MeSH Terms:: DNA Methylation*
Breast Neoplasms*/genetics
Breast Neoplasms*/pathology
Humans ; Female ; East Asian People ; Breast ; Epigenesis, Genetic ; Aging/genetics

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 4.

Tytuł:: Disinfection By-Products in Drinking Water and Bladder Cancer: Evaluation of Risk Modification by Common Genetic Polymorphisms in Two Case-Control Studies.
Autorzy:: Beane Freeman LE; Barcelona Institute for Global Health, Barcelona, Spain.
Kogevinas M; Barcelona Institute for Global Health, Barcelona, Spain.; CIBER Epidemiologia y Salud Pública, Madrid, Spain.; Universitat Pompeu Fabra (UPF), Barcelona, Spain.; Hospital del Mar Medical Research Institute, Barcelona, Spain.
Cantor KP; Occupational and Environmental Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute (NCI), National Institutes of Health (NIH), Department of Health and Human Services (DHHS), Bethesda, Maryland, USA.
Villanueva CM; Barcelona Institute for Global Health, Barcelona, Spain.; CIBER Epidemiologia y Salud Pública, Madrid, Spain.; Universitat Pompeu Fabra (UPF), Barcelona, Spain.; Hospital del Mar Medical Research Institute, Barcelona, Spain.
Prokunina-Olsson L; Laboratory of Translational Genomics, Division of Cancer Epidemiology and Genetics, NCI, NIH, DHHS, Bethesda, Maryland, USA.
Florez-Vargas O; Laboratory of Translational Genomics, Division of Cancer Epidemiology and Genetics, NCI, NIH, DHHS, Bethesda, Maryland, USA.
Figueroa JD; Usher Institute, University of Edinburgh, Edinburgh, UK.; Cancer Research UK Edinburgh Centre, University of Edinburgh, Edinburgh, UK.
Ward MH; Occupational and Environmental Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute (NCI), National Institutes of Health (NIH), Department of Health and Human Services (DHHS), Bethesda, Maryland, USA.
Koutros S; Occupational and Environmental Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute (NCI), National Institutes of Health (NIH), Department of Health and Human Services (DHHS), Bethesda, Maryland, USA.
Baris D; Occupational and Environmental Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute (NCI), National Institutes of Health (NIH), Department of Health and Human Services (DHHS), Bethesda, Maryland, USA.
Garcia-Closas M; Trans-Divisional Research Program, Division of Cancer Epidemiology and Genetics, NCI, NIH, DHHS, Bethesda, Maryland, USA.
Schwenn M; Maine Cancer Registry, Augusta, Maine, USA.
Johnson A; Occupational and Environmental Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute (NCI), National Institutes of Health (NIH), Department of Health and Human Services (DHHS), Bethesda, Maryland, USA.
Serra C; Occupational and Environmental Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute (NCI), National Institutes of Health (NIH), Department of Health and Human Services (DHHS), Bethesda, Maryland, USA.; Barcelona Institute for Global Health, Barcelona, Spain.; CIBER Epidemiologia y Salud Pública, Madrid, Spain.; Hospital del Mar Medical Research Institute, Barcelona, Spain.
Tardon A; Occupational and Environmental Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute (NCI), National Institutes of Health (NIH), Department of Health and Human Services (DHHS), Bethesda, Maryland, USA.; CIBER Epidemiologia y Salud Pública, Madrid, Spain.
Garcia-Closas R; Occupational and Environmental Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute (NCI), National Institutes of Health (NIH), Department of Health and Human Services (DHHS), Bethesda, Maryland, USA.; Universitat Pompeu Fabra (UPF), Barcelona, Spain.
Carrato A; Medical Oncology Department, Ramón y Cajal University Hospital, Madrid, Spain.; Alcalá University, Madrid, Spain.; Instituto Ramón y Cajal de Investigación Sanitaria, Madrid, Spain.; Centro de Investigación Biomédica en Red Cáncer, Madrid, Spain.
Malats N; Occupational and Environmental Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute (NCI), National Institutes of Health (NIH), Department of Health and Human Services (DHHS), Bethesda, Maryland, USA.; Cancer Research UK Edinburgh Centre, University of Edinburgh, Edinburgh, UK.; Trans-Divisional Research Program, Division of Cancer Epidemiology and Genetics, NCI, NIH, DHHS, Bethesda, Maryland, USA.
Karagas MR; Department of Epidemiology, Geisel School of Medicine at Dartmouth, Hanover, New Hampshire, USA.
Rothman N; Barcelona Institute for Global Health, Barcelona, Spain.
Silverman DT; Barcelona Institute for Global Health, Barcelona, Spain.; Pokaż więcej
Źródło:: Environmental health perspectives [Environ Health Perspect] 2022 May; Vol. 130 (5), pp. 57006. Date of Electronic Publication: 2022 May 10.
Typ publikacji:: Journal Article; Meta-Analysis
MeSH Terms:: Disinfectants*/analysis
Drinking Water*
Urinary Bladder Neoplasms*/chemically induced
Urinary Bladder Neoplasms*/epidemiology
Urinary Bladder Neoplasms*/genetics
Water Pollutants, Chemical*/analysis
Water Pollutants, Chemical*/toxicity
Case-Control Studies ; Disinfection ; Female ; Genome-Wide Association Study ; Humans ; Logistic Models ; Male ; Polymorphism, Genetic ; Trihalomethanes/analysis ; Trihalomethanes/toxicity

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 5.

Tytuł:: iCARE: An R package to build, validate and apply absolute risk models.
Autorzy:: Pal Choudhury P; Department of Biostatistics, The Johns Hopkins University, Baltimore, MD, United States of America.; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, United States of America.
Maas P; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, United States of America.
Wilcox A; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, United States of America.; Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States of America.
Wheeler W; Information Management Services, Silver Spring, MD, United States of America.
Brook M; Division of Genetics and Epidemiology, Institute of Cancer Research, London, United Kingdom.
Check D; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, United States of America.
Garcia-Closas M; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, United States of America.
Chatterjee N; Department of Biostatistics, The Johns Hopkins University, Baltimore, MD, United States of America.; Department of Oncology, The Johns Hopkins University, Baltimore, MD, United States of America.; Pokaż więcej
Źródło:: PloS one [PLoS One] 2020 Feb 05; Vol. 15 (2), pp. e0228198. Date of Electronic Publication: 2020 Feb 05 (Print Publication: 2020).
Typ publikacji:: Journal Article; Research Support, N.I.H., Intramural; Research Support, Non-U.S. Gov't
MeSH Terms:: Software*
Genome-Wide Association Study/*methods
Area Under Curve ; Breast Neoplasms/genetics ; Breast Neoplasms/pathology ; Female ; Humans ; Polymorphism, Single Nucleotide ; ROC Curve ; Risk Factors

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 6.

Tytuł:: Recruiting population controls for case-control studies in sub-Saharan Africa: The Ghana Breast Health Study.
Autorzy:: Nyante SJ; University of North Carolina at Chapel Hill, Chapel Hill, NC, United States of America.
Biritwum R; University of Ghana, Accra, Ghana.
Figueroa J; University of Edinburgh, Edinburgh, Scotland.
Graubard B; National Cancer Institute, Rockville, MD, United States of America.
Awuah B; Komfo Anokye Teaching Hospital, Kumasi, Ghana.
Addai BW; Peace and Love Hospital, Kumasi, Ghana.
Yarney J; Korle Bu Teaching Hospital, Accra, Ghana.
Clegg-Lamptey JN; Korle Bu Teaching Hospital, Accra, Ghana.
Ansong D; Komfo Anokye Teaching Hospital, Kumasi, Ghana.
Nyarko K; University of Ghana, Accra, Ghana.
Wiafe S; Peace and Love Hospital, Kumasi, Ghana.
Oppong J; Komfo Anokye Teaching Hospital, Kumasi, Ghana.
Boakye I; Komfo Anokye Teaching Hospital, Kumasi, Ghana.
Brotzman M; National Cancer Institute, Rockville, MD, United States of America.
Adjei R; Ghana Statistical Service, Accra, Ghana.
Afriyie LT; Ghana Statistical Service, Accra, Ghana.
Garcia-Closas M; National Cancer Institute, Rockville, MD, United States of America.
Brinton LA; National Cancer Institute, Rockville, MD, United States of America.; Pokaż więcej
Źródło:: PloS one [PLoS One] 2019 Apr 16; Vol. 14 (4), pp. e0215347. Date of Electronic Publication: 2019 Apr 16 (Print Publication: 2019).
Typ publikacji:: Clinical Trial; Journal Article; Research Support, N.I.H., Extramural; Research Support, N.I.H., Intramural
MeSH Terms:: Registries*
Breast Neoplasms/*epidemiology
Adolescent ; Adult ; Aged ; Case-Control Studies ; Female ; Ghana/epidemiology ; Humans ; Middle Aged

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 7.

Tytuł:: Winner's Curse Correction and Variable Thresholding Improve Performance of Polygenic Risk Modeling Based on Genome-Wide Association Study Summary-Level Data.
Autorzy:: Shi J; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, United States of America.
Park JH; Department of Statistics, Dongguk University, Seoul, Korea.
Duan J; Center for Psychiatric Genetics, Department of Psychiatry and Behavioral Sciences, North Shore University Health System Research Institute, University of Chicago Pritzker School of Medicine, Evanston, Illinois, United States of America.
Berndt ST; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, United States of America.
Moy W; Dept. of Statistics, Northern Illinois University, DeKalb, Illinois, United States of America.
Yu K; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, United States of America.
Song L; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, United States of America.
Wheeler W; Information Management Services, Inc., Rockville, Maryland, United States of America.
Hua X; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, United States of America.
Silverman D; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, United States of America.
Garcia-Closas M; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, United States of America.
Hsiung CA; Institute of Population Health Sciences, National Health Research Institutes, Miaoli, Taiwan.
Figueroa JD; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, United States of America.; Usher Institute of Population Health Sciences and Informatics, The University of Edinburgh, Medical School, Edinburgh, United Kingdom.
Cortessis VK; Department of Preventive Medicine and Department of Obstetrics and Gynecology, USC Keck School of Medicine, University of Southern California, Los Angeles, California, United States of America.; Norris Comprehensive Cancer Center, USC Keck School of Medicine, University of Southern California, Los Angeles, California, United States of America.
Malats N; Genetic and Molecular Epidemiology Group, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.
Karagas MR; Geisel School of Medicine, Dartmouth College, Hanover, New Hampshire, United States of America.
Vineis P; Human Genetics Foundation, Turin, Italy.; MRC-PHE Centre for Environment and Health, School of Public Health, Imperial College London, London, United Kingdom.
Chang IS; National Institute of Cancer Research, National Health Research Institutes, Zhunan, Taiwan.
Lin D; Department of Etiology & Carcinogenesis, Cancer Institute and Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.; State Key Laboratory of Molecular Oncology, Cancer Institute and Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Zhou B; Department of Epidemiology, School of Public Health, China Medical University, Shenyang, China.
Seow A; Saw Swee Hock School of Public Health, National University of Singapore, Singapore.
Matsuo K; Division of Molecular Medicine, Aichi Cancer Center Research Institute, Chikusa-ku, Nagoya, Japan.
Hong YC; Department of Preventive Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea.
Caporaso NE; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, United States of America.
Wolpin B; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, United States of America.; Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, United States of America.
Jacobs E; Epidemiology Research Program, American Cancer Society, Atlanta, Georgia, United States of America.
Petersen GM; Division of Epidemiology, Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota, United States of America.
Klein AP; Department of Oncology, the Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America.; Department of Epidemiology, the Bloomberg School of Public Health, Baltimore, Maryland, United States of America.
Li D; Department of Gastrointestinal Medical Oncology, University of Texas M.D. Anderson Cancer Center, Houston, Texas, United States of America.
Risch H; Department of Chronic Disease Epidemiology, Yale School of Public Health, New Haven, Connecticut, United States of America.
Sanders AR; Center for Psychiatric Genetics, Department of Psychiatry and Behavioral Sciences, North Shore University Health System Research Institute, University of Chicago Pritzker School of Medicine, Evanston, Illinois, United States of America.
Hsu L; Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America.
Schoen RE; Department of Medicine and Epidemiology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, United States of America.
Brenner H; Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Division of Preventive Oncology, German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT), Heidelberg, Germany.; German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany.
Stolzenberg-Solomon R; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, United States of America.
Gejman P; Center for Psychiatric Genetics, Department of Psychiatry and Behavioral Sciences, North Shore University Health System Research Institute, University of Chicago Pritzker School of Medicine, Evanston, Illinois, United States of America.
Lan Q; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, United States of America.
Rothman N; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, United States of America.
Amundadottir LT; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, United States of America.
Landi MT; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, United States of America.
Levinson DF; Department of Psychiatry and Behavioral Sciences, Stanford University, Stanford, California, United States of America.
Chanock SJ; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, United States of America.
Chatterjee N; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, United States of America.; Department of Biostatistics, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland, United States of America.; Department of Oncology, School of Medicine, Johns Hopkins University, Baltimore, Maryland, United States of America.; Pokaż więcej
Corporate Authors:: MGS (Molecular Genetics of Schizophrenia) GWAS Consortium
GECCO (The Genetics and Epidemiology of Colorectal Cancer Consortium)
GAME-ON/TRICL (Transdisciplinary Research in Cancer of the Lung) GWAS Consortium
PRACTICAL (PRostate cancer AssoCiation group To Investigate Cancer Associated aLterations) Consortium
PanScan Consortium
GAME-ON/ELLIPSE Consortium
Źródło:: PLoS genetics [PLoS Genet] 2016 Dec 30; Vol. 12 (12), pp. e1006493. Date of Electronic Publication: 2016 Dec 30 (Print Publication: 2016).
Typ publikacji:: Journal Article
MeSH Terms:: Genetic Predisposition to Disease*
Models, Genetic*
Genome-Wide Association Study/*methods
Multifactorial Inheritance/*genetics
Algorithms ; Computer Simulation ; Humans ; Linkage Disequilibrium ; Polymorphism, Single Nucleotide ; Risk Factors

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 8.

Tytuł:: Genetically Predicted Body Mass Index and Breast Cancer Risk: Mendelian Randomization Analyses of Data from 145,000 Women of European Descent.
Autorzy:: Guo Y; Department of Cancer Biology, Vanderbilt University, Nashville, Tennessee, United States of America.
Warren Andersen S; Division of Epidemiology, Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee, United States of America.
Shu XO; Division of Epidemiology, Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee, United States of America.
Michailidou K; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom.
Bolla MK; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom.
Wang Q; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom.
Garcia-Closas M; Division of Genetics and Epidemiology, The Institute of Cancer Research, London, United Kingdom.; Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, United Kingdom.
Milne RL; Cancer Epidemiology Centre, Cancer Council Victoria, Melbourne, Australia.; Centre for Epidemiology and Biostatistics, School of Population and Global health, The University of Melbourne, Melbourne, Australia.
Schmidt MK; Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, The Netherlands.
Chang-Claude J; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Department of Obstetrics and Gynecology, University of Ulm, Ulm, Germany.
Dunning A; Academic Unit of Pathology, Department of Neuroscience, University of Sheffield, Sheffield, United Kingdom.
Bojesen SE; Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.; Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Herlev, Denmark.; Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Herlev, Denmark.
Ahsan H; Department of Health Studies, The University of Chicago, Chicago, Illinois, United States of America.
Aittomäki K; Department of Clinical Genetics, Helsinki University Hospital, University of Helsinki, Helsinki, Finland.
Andrulis IL; Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Toronto, Canada.; Department of Molecular Genetics, University of Toronto, Toronto, Canada.
Anton-Culver H; Department of Epidemiology, University of California Irvine, Irvine, California, United States of America.
Arndt V; Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Beckmann MW; Department of Health Studies, The University of Chicago, Chicago, Illinois, United States of America.
Beeghly-Fadiel A; Division of Epidemiology, Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee, United States of America.
Benitez J; Human Cancer Genetics Program, Spanish National Cancer Research Centre, Madrid, Spain.; Centro de Investigación en Red de Enfermedades Raras, Valencia, Spain.
Bogdanova NV; Department of Radiation Oncology, Hannover Medical School, Hannover, Germany.
Bonanni B; Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia, Milan, Italy.
Børresen-Dale AL; Department of Genetics, Institute for Cancer Research, Radiumhospitalet, Oslo University Hospital, Oslo University Hospital, Oslo, Norway.; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.
Brand J; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
Brauch H; German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany.; Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology, Stuttgart, Germany.; University of Tübingen, Tübingen, Germany.
Brenner H; Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany.; German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany.; Division of Preventive Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Brüning T; Institute for Prevention and Occupational Medicine of the German Social Accident Insurance, Institute of the Ruhr University Bochum, Bochum, Germany.
Burwinkel B; Division of Molecular Genetic Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Molecular Epidemiology Group, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Casey G; Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California, United States of America.
Chenevix-Trench G; Department of Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia.
Couch FJ; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, United States of America.
Cox A; Sheffield Cancer Research, Department of Oncology, University of Sheffield, Sheffield, United Kingdom.
Cross SS; Academic Unit of Pathology, Department of Neuroscience, University of Sheffield, Sheffield, United Kingdom.
Czene K; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
Devilee P; Department of Human Genetics, Leiden University Medical Center, Leiden, The Netherlands.
Dörk T; Gynaecology Research Unit, Hannover Medical School, Hannover, Germany.
Dumont M; Centre Hospitalier Universitaire de Québec Research Center, Laval University, Québec City, Canada.
Fasching PA; Department of Gynaecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-EMN, Erlangen, Germany.; David Geffen School of Medicine, Department of Medicine Division of Hematology and Oncology, University of California at Los Angeles, Los Angeles, California, United States of America.
Figueroa J; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland, United States of America.
Flesch-Janys D; Institute for Medical Biometrics and Epidemiology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.; Department of Cancer Epidemiology, Clinical Cancer Registry, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Fletcher O; Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, United Kingdom.
Flyger H; Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Herlev, Denmark.
Fostira F; Molecular Diagnostics Laboratory, IRRP, National Centre for Scientific Research 'Demokritos', Athens, Greece.
Gammon M; Departments of Epidemiology, University of North Carolina Chapel-Hill, Chapel Hill, North Carolina, United States of America.
Giles GG; Cancer Epidemiology Centre, Cancer Council Victoria, Melbourne, Australia.; Centre for Epidemiology and Biostatistics, School of Population and Global health, The University of Melbourne, Melbourne, Australia.
Guénel P; Environmental Epidemiology of Cancer, Center for Research in Epidemiology and Population Health, INSERM, Villejuif, France.; University Paris-Sud, Villejuif, France.
Haiman CA; Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California, United States of America.
Hamann U; Molecular Genetics of Breast Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Hooning MJ; Department of Surgical Oncology, Erasmus University Medical Center, Rotterdam, The Netherlands.
Hopper JL; Centre for Epidemiology and Biostatistics, School of Population and Global health, The University of Melbourne, Melbourne, Australia.
Jakubowska A; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland.
Jasmine F; Department of Health Studies, The University of Chicago, Chicago, Illinois, United States of America.
Jenkins M; Centre for Epidemiology and Biostatistics, School of Population and Global health, The University of Melbourne, Melbourne, Australia.
John EM; Department of Epidemiology, Cancer Prevention Institute of California, Fremont, California, United States of America.; Department of Health Research and Policy, Stanford University School of Medicine, Stanford, California, United States of America.
Johnson N; Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, United Kingdom.
Jones ME; Division of Genetics and Epidemiology, The Institute of Cancer Research, London, United Kingdom.
Kabisch M; Molecular Genetics of Breast Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Kibriya M; Department of Health Studies, The University of Chicago, Chicago, Illinois, United States of America.
Knight JA; Prosserman Centre for Health Research, Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Toronto, Canada.; Division of Epidemiology, Dalla Lana School of Public Health, University of Toronto, Toronto, Canada.
Koppert LB; Department of Surgical Oncology, Erasmus University Medical Center, Rotterdam, The Netherlands.
Kosma VM; Imaging Center, Department of Clinical Pathology, Kuopio University Hospital, Kuopio, Finland.; Institute of Clinical Medicine, Pathology and Forensic Medicine, University of Eastern Finland, Kuopio, Finland.; Cancer Center of Eastern Finland, University of Eastern Finland, Kuopio, Finland.
Kristensen V; Department of Genetics, Institute for Cancer Research, Radiumhospitalet, Oslo University Hospital, Oslo University Hospital, Oslo, Norway.; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.; Department of Clinical Molecular Biology, Oslo University Hospital, University of Oslo, Oslo, Norway.
Le Marchand L; University of Hawaii Cancer Center, Honolulu, Hawaii, United States of America.
Lee E; Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California, United States of America.
Li J; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
Lindblom A; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
Luben R; Clinical Gerontology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom.
Lubinski J; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland.
Malone KE; Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America.
Mannermaa A; Imaging Center, Department of Clinical Pathology, Kuopio University Hospital, Kuopio, Finland.; Institute of Clinical Medicine, Pathology and Forensic Medicine, University of Eastern Finland, Kuopio, Finland.; Cancer Center of Eastern Finland, University of Eastern Finland, Kuopio, Finland.
Margolin S; Department of Oncology - Pathology, Karolinska Institutet, Stockholm, Sweden.
Marme F; National Center for Tumor Diseases, University of Heidelberg, Heidelberg, Germany.; Department of Obstetrics and Gynecology, University of Heidelberg, Heidelberg, Germany.
McLean C; Anatomical Pathology, The Alfred Hospital, Melbourne, Australia.
Meijers-Heijboer H; Department of Clinical Genetics, VU University Medical Center, Amsterdam, The Netherlands.
Meindl A; Division of Gynaecology and Obstetrics, Technische Universität München, Munich, Germany.
Neuhausen SL; Beckman Research Institute of City of Hope, Duarte, California, United States of America.
Nevanlinna H; Department of Obstetrics and Gynecology, Helsinki University Hospital, University of Helsinki, Helsinki, Finland.
Neven P; Department of Oncology, University Hospital Gasthuisberg, Leuven, Belgium.
Olson JE; Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota, United States of America.
Perez JI; Servicio de Cirugía General y Especialidades, Hospital Monte Naranco, Oviedo, Spain.
Perkins B; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, United Kingdom.
Peterlongo P; IFOM, Fondazione Istituto FIRC (Italian Foundation of Cancer Research) di Oncologia Molecolare, Milan, Italy.
Phillips KA; Peter MacCallum Cancer Center, The University of Melbourne, Melbourne, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Australia.; Department of Medicine, St Vincent's Hospital, The University of Melbourne, Fitzroy, Australia.
Pylkäs K; Laboratory of Cancer Genetics and Tumor Biology, Department of Clinical Chemistry and Biocenter Oulu, University of Oulu, Oulu, Finland.
Rudolph A; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Santella R; Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York, New York, United States of America.; Department of Environmental Health Sciences, Mailman School of Public Health of Columbia University, New York, New York, United States of America.
Sawyer EJ; Research Oncology, Guy's Hospital, King's College London, London, United Kingdom.
Schmutzler RK; Division of Molecular Gyneco-Oncology, Department of Gynaecology and Obstetrics, University Hospital of Cologne, Cologne, Germany.; Center for Integrated Oncology, University Hospital of Cologne, Cologne, Germany.; Center for Molecular Medicine, University Hospital of Cologne, Cologne, Germany.; Center of Familial Breast and Ovarian Cancer, University Hospital of Cologne, Cologne, Germany.
Seynaeve C; Department of Surgical Oncology, Erasmus University Medical Center, Rotterdam, The Netherlands.
Shah M; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, United Kingdom.
Shrubsole MJ; Division of Epidemiology, Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee, United States of America.
Southey MC; Department of Pathology, The University of Melbourne, Melbourne, Australia.
Swerdlow AJ; Division of Genetics and Epidemiology, The Institute of Cancer Research, London, United Kingdom.; Division of Breast Cancer Research, The Institute of Cancer Research, London, United Kingdom.
Toland AE; Department of Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio, United States of America.
Tomlinson I; Wellcome Trust Centre for Human Genetics and Oxford Biomedical Research Centre, University of Oxford, Oxford, United Kingdom.
Torres D; Molecular Genetics of Breast Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Truong T; Environmental Epidemiology of Cancer, Center for Research in Epidemiology and Population Health, INSERM, Villejuif, France.; University Paris-Sud, Villejuif, France.
Ursin G; Department of Nutrition, Institute of Basic Medical Sciences, University of Oslo, Oslo, Norway.
Van Der Luijt RB; Department of Medical Genetics, University Medical Center Utrecht, Utrecht, The Netherlands.
Verhoef S; Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, The Netherlands.
Whittemore AS; Department of Health Research and Policy, Stanford University School of Medicine, Stanford, California, United States of America.
Winqvist R; Laboratory of Cancer Genetics and Tumor Biology, Department of Clinical Chemistry and Biocenter Oulu, University of Oulu, Oulu, Finland.; Laboratory of Cancer Genetics and Tumor Biology, Northern Finland Laboratory Centre NordLab, Oulu, Finland.
Zhao H; Vesalius Research Center, Leuven, Belgium.; Laboratory for Translational Genetics, Department of Oncology, University of Leuven, Leuven, Belgium.
Zhao S; Department of Cancer Biology, Vanderbilt University, Nashville, Tennessee, United States of America.
Hall P; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
Simard J; Centre Hospitalier Universitaire de Québec Research Center, Laval University, Québec City, Canada.
Kraft P; Program in Genetic Epidemiology and Statistical Genetics, Harvard School of Public Health, Boston, Massachusetts, United States of America.; Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts, United States of America.
Pharoah P; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom.; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, United Kingdom.
Hunter D; Program in Genetic Epidemiology and Statistical Genetics, Harvard School of Public Health, Boston, Massachusetts, United States of America.; Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts, United States of America.
Easton DF; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom.; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, United Kingdom.
Zheng W; Division of Epidemiology, Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee, United States of America.; Pokaż więcej
Źródło:: PLoS medicine [PLoS Med] 2016 Aug 23; Vol. 13 (8), pp. e1002105. Date of Electronic Publication: 2016 Aug 23 (Print Publication: 2016).
Typ publikacji:: Journal Article
MeSH Terms:: Body Mass Index*
Breast Neoplasms/*genetics
White People/*genetics
Breast Neoplasms/etiology ; Female ; Genetic Predisposition to Disease/genetics ; Humans ; Mendelian Randomization Analysis ; Menopause ; Middle Aged ; Models, Statistical ; Polymorphism, Single Nucleotide/genetics ; Risk Factors ; White People/statistics & numerical data

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 9.

Tytuł:: Epigenome-wide association study reveals decreased average methylation levels years before breast cancer diagnosis.
Autorzy:: van Veldhoven K; MRC-PHE Centre for Environment and Health, Imperial College London, London, W2 1PG UK.; HuGeF Foundation, 52, Via Nizza, Torino, 10126 Italy.
Polidoro S; HuGeF Foundation, 52, Via Nizza, Torino, 10126 Italy.
Baglietto L; HuGeF Foundation, 52, Via Nizza, Torino, 10126 Italy.
Severi G; HuGeF Foundation, 52, Via Nizza, Torino, 10126 Italy.
Sacerdote C; HuGeF Foundation, 52, Via Nizza, Torino, 10126 Italy.
Panico S; Departimento di Medicina Clinica e Chirurgia, Federico II University, Naples, Italy.
Mattiello A; Departimento di Medicina Clinica e Chirurgia, Federico II University, Naples, Italy.
Palli D; Molecular and Nutritional Epidemiology Unit, Cancer Research and Prevention Institute-ISPO, Florence, Italy.
Masala G; Molecular and Nutritional Epidemiology Unit, Cancer Research and Prevention Institute-ISPO, Florence, Italy.
Krogh V; Epidemiology and Prevention Unit Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
Agnoli C; Epidemiology and Prevention Unit Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
Tumino R; Cancer Registry ASP, Ragusa, Italy.
Frasca G; Cancer Registry ASP, Ragusa, Italy.
Flower K; Epigenetics Unit, Division of Cancer, Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, 4th Floor IRDB, Hammersmith Campus, Du Cane Road, London, W12 0NN UK.
Curry E; Epigenetics Unit, Division of Cancer, Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, 4th Floor IRDB, Hammersmith Campus, Du Cane Road, London, W12 0NN UK.
Orr N; Division of Breast Cancer Research, The Institute of Cancer Research, London, UK.
Tomczyk K; Division of Breast Cancer Research, The Institute of Cancer Research, London, UK.
Jones ME; Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK.
Ashworth A; Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK.
Swerdlow A; Division of Breast Cancer Research, The Institute of Cancer Research, London, UK.; Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK.
Chadeau-Hyam M; MRC-PHE Centre for Environment and Health, Imperial College London, London, W2 1PG UK.
Lund E; Department of Community Medicine, UiT-the Arctic University of Norway, Tromsø, Norway.
Garcia-Closas M; Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK.; Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK.
Sandanger TM; Department of Community Medicine, UiT-the Arctic University of Norway, Tromsø, Norway.
Flanagan JM; Epigenetics Unit, Division of Cancer, Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, 4th Floor IRDB, Hammersmith Campus, Du Cane Road, London, W12 0NN UK.
Vineis P; MRC-PHE Centre for Environment and Health, Imperial College London, London, W2 1PG UK.; HuGeF Foundation, 52, Via Nizza, Torino, 10126 Italy.; Pokaż więcej
Źródło:: Clinical epigenetics [Clin Epigenetics] 2015 Aug 04; Vol. 7, pp. 67. Date of Electronic Publication: 2015 Aug 04 (Print Publication: 2015).
Typ publikacji:: Journal Article

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 10.

Tytuł:: Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer.
Autorzy:: Michailidou K; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
Beesley J; Department of Genetics, QIMR (Queensland Institute for Medical Research) Berghofer Medical Research Institute, Brisbane, Queensland, Australia.
Lindstrom S; Program in Genetic Epidemiology and Statistical Genetics, Harvard School of Public Health, Boston, Massachusetts, USA.
Canisius S; Division of Molecular Carcinogenesis, Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands.
Dennis J; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
Lush MJ; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
Maranian MJ; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK.
Bolla MK; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
Wang Q; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
Shah M; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK.
Perkins BJ; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK.
Czene K; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
Eriksson M; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
Darabi H; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
Brand JS; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
Bojesen SE; 1] Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Herlev, Denmark. [2] Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Herlev, Denmark. [3] Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Nordestgaard BG; 1] Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Herlev, Denmark. [2] Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Herlev, Denmark. [3] Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Flyger H; Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Herlev, Denmark.
Nielsen SF; 1] Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Herlev, Denmark. [2] Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Herlev, Denmark.
Rahman N; Division of Genetics and Epidemiology, Institute of Cancer Research, London, UK.
Turnbull C; Division of Genetics and Epidemiology, Institute of Cancer Research, London, UK.
Fletcher O; Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK.
Peto J; Department of Non-Communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK.
Gibson L; Department of Non-Communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK.
dos-Santos-Silva I; Department of Non-Communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK.
Chang-Claude J; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Flesch-Janys D; 1] Department of Cancer Epidemiology/Clinical Cancer Registry, University Clinic Hamburg-Eppendorf, Hamburg, Germany. [2] Institute for Medical Biometrics and Epidemiology, University Clinic Hamburg-Eppendorf, Hamburg, Germany.
Rudolph A; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Eilber U; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Behrens S; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Nevanlinna H; Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland.
Muranen TA; Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland.
Aittomäki K; Department of Clinical Genetics, Helsinki University Central Hospital, Helsinki, Finland.
Blomqvist C; Department of Oncology, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland.
Khan S; Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland.
Aaltonen K; Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland.
Ahsan H; 1] Center for Cancer Epidemiology and Prevention, University of Chicago, Chicago, Illinois, USA. [2] Department of Health Studies, University of Chicago, Chicago, Illinois, USA. [3] Department of Medicine, University of Chicago, Chicago, Illinois, USA. [4] Department of Human Genetics, University of Chicago, Chicago, Illinois, USA. [5] Comprehensive Cancer Center, University of Chicago, Chicago, Illinois, USA.
Kibriya MG; 1] Center for Cancer Epidemiology and Prevention, University of Chicago, Chicago, Illinois, USA. [2] Department of Health Studies, University of Chicago, Chicago, Illinois, USA.
Whittemore AS; 1] Department of Health Research and Policy-Epidemiology, Stanford University School of Medicine, Stanford, California, USA. [2] Stanford Cancer Institute, Stanford University School of Medicine, Stanford, California, USA.
John EM; 1] Department of Health Research and Policy-Epidemiology, Stanford University School of Medicine, Stanford, California, USA. [2] Stanford Cancer Institute, Stanford University School of Medicine, Stanford, California, USA. [3] Department of Epidemiology, Cancer Prevention Institute of California, Fremont, California, USA.
Malone KE; Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
Gammon MD; Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
Santella RM; Department of Environmental Health Sciences, Columbia University Mailman School of Public Health, New York, New York, USA.
Ursin G; Cancer Registry of Norway, Oslo, Norway.
Makalic E; Centre for Molecular, Environmental, Genetic and Analytic Epidemiology, Melbourne School of Population Health, Melbourne, Victoria, Australia.
Schmidt DF; Centre for Molecular, Environmental, Genetic and Analytic Epidemiology, Melbourne School of Population Health, Melbourne, Victoria, Australia.
Casey G; Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California, USA.
Hunter DJ; Program in Genetic Epidemiology and Statistical Genetics, Harvard School of Public Health, Boston, Massachusetts, USA.
Gapstur SM; Epidemiology Research Program, American Cancer Society, Atlanta, Georgia, USA.
Gaudet MM; Epidemiology Research Program, American Cancer Society, Atlanta, Georgia, USA.
Diver WR; Epidemiology Research Program, American Cancer Society, Atlanta, Georgia, USA.
Haiman CA; Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California, USA.
Schumacher F; Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California, USA.
Henderson BE; Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California, USA.
Le Marchand L; Epidemiology Program, University of Hawaii Cancer Center, Honolulu, Hawaii, USA.
Berg CD; Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins Medicine, Baltimore, Maryland, USA.
Chanock SJ; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland, USA.
Figueroa J; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland, USA.
Hoover RN; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland, USA.
Lambrechts D; 1] Vesalius Research Center, VIB, Leuven, Belgium. [2] Laboratory for Translational Genetics, Department of Oncology, University of Leuven, Leuven, Belgium.
Neven P; Multidisciplinary Breast Center, University Hospitals Leuven, Leuven, Belgium.
Wildiers H; Multidisciplinary Breast Center, University Hospitals Leuven, Leuven, Belgium.
van Limbergen E; Multidisciplinary Breast Center, University Hospitals Leuven, Leuven, Belgium.
Schmidt MK; Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands.
Broeks A; Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands.
Verhoef S; Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands.
Cornelissen S; Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands.
Couch FJ; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA.
Olson JE; Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota, USA.
Hallberg E; Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota, USA.
Vachon C; Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota, USA.
Waisfisz Q; Department of Clinical Genetics, Section Oncogenetics, VU University Medical Center, Amsterdam, the Netherlands.
Meijers-Heijboer H; Department of Clinical Genetics, Section Oncogenetics, VU University Medical Center, Amsterdam, the Netherlands.
Adank MA; Department of Clinical Genetics, Section Oncogenetics, VU University Medical Center, Amsterdam, the Netherlands.
van der Luijt RB; Division of Biomedical Genetics, University Medical Center Utrecht, Utrecht, the Netherlands.
Li J; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
Liu J; Human Genetics Division, Genome Institute of Singapore, Singapore.
Humphreys K; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
Kang D; 1] Department of Preventive Medicine, Seoul National University College of Medicine, Seoul, Korea. [2] Department of Biomedical Sciences, Seoul National University Graduate School, Seoul, Korea. [3] Cancer Research Institute, Seoul National University, Seoul, Korea.
Choi JY; 1] Department of Biomedical Sciences, Seoul National University Graduate School, Seoul, Korea. [2] Cancer Research Institute, Seoul National University, Seoul, Korea.
Park SK; 1] Department of Preventive Medicine, Seoul National University College of Medicine, Seoul, Korea. [2] Department of Biomedical Sciences, Seoul National University Graduate School, Seoul, Korea. [3] Cancer Research Institute, Seoul National University, Seoul, Korea.
Yoo KY; Seoul National University College of Medicine, Seoul, Korea.
Matsuo K; Department of Preventive Medicine, Kyushu University Faculty of Medical Sciences, Fukuoka, Japan.
Ito H; Division of Epidemiology and Prevention, Aichi Cancer Center Research Institute, Nagoya, Japan.
Iwata H; Department of Breast Oncology, Aichi Cancer Center Hospital, Nagoya, Japan.
Tajima K; Epidemiology Center for Disease Control and Prevention, Mie University Hospital, Tsu, Japan.
Guénel P; 1] INSERM), CESP (Center for Research in Epidemiology and Population Health), U1018, Environmental Epidemiology of Cancer, Villejuif, France. [2] University Paris-Sud, UMRS 1018, Villejuif, France.
Truong T; 1] INSERM), CESP (Center for Research in Epidemiology and Population Health), U1018, Environmental Epidemiology of Cancer, Villejuif, France. [2] University Paris-Sud, UMRS 1018, Villejuif, France.
Mulot C; Université Paris Sorbonne Cité, UMRS 775, INSERM, Paris, France.
Sanchez M; 1] INSERM), CESP (Center for Research in Epidemiology and Population Health), U1018, Environmental Epidemiology of Cancer, Villejuif, France. [2] University Paris-Sud, UMRS 1018, Villejuif, France.
Burwinkel B; 1] Department of Obstetrics and Gynecology, University of Heidelberg, Heidelberg, Germany. [2] Molecular Epidemiology Group, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Marme F; 1] Department of Obstetrics and Gynecology, University of Heidelberg, Heidelberg, Germany. [2] National Center for Tumor Diseases, University of Heidelberg, Heidelberg, Germany.
Surowy H; 1] Department of Obstetrics and Gynecology, University of Heidelberg, Heidelberg, Germany. [2] Molecular Epidemiology Group, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Sohn C; Department of Obstetrics and Gynecology, University of Heidelberg, Heidelberg, Germany.
Wu AH; Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California, USA.
Tseng CC; Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California, USA.
Van Den Berg D; Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California, USA.
Stram DO; Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California, USA.
González-Neira A; Human Genotyping (CEGEN) Unit, Human Cancer Genetics Program, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.
Benitez J; 1] Human Genotyping (CEGEN) Unit, Human Cancer Genetics Program, Spanish National Cancer Research Centre (CNIO), Madrid, Spain. [2] Centro de Investigación en Red de Enfermedades Raras (CIBERER), Valencia, Spain.
Zamora MP; Servicio de Oncología Médica, Hospital Universitario La Paz, Madrid, Spain.
Perez JI; Servicio de Cirugía General y Especialidades, Hospital Monte Naranco, Oviedo, Spain.
Shu XO; Department of Medicine, Division of Epidemiology, Vanderbilt Epidemiology Center and Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee, USA.
Lu W; Shanghai Center for Disease Control and Prevention, Changning, China.
Gao YT; Department of Epidemiology, Shanghai Cancer Institute, Shanghai, China.
Cai H; Department of Medicine, Division of Epidemiology, Vanderbilt Epidemiology Center and Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee, USA.
Cox A; 1] Sheffield Cancer Research Centre, University of Sheffield, Sheffield, UK. [2] Department of Oncology, University of Sheffield, Sheffield, UK.
Cross SS; Academic Unit of Pathology, Department of Neuroscience, University of Sheffield, Sheffield, UK.
Reed MW; 1] Sheffield Cancer Research Centre, University of Sheffield, Sheffield, UK. [2] Department of Oncology, University of Sheffield, Sheffield, UK.
Andrulis IL; 1] Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Toronto, Ontario, Canada. [2] Department of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada.
Knight JA; 1] Prosserman Centre for Health Research, Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Toronto, Ontario, Canada. [2] Division of Epidemiology, Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada.
Glendon G; Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Toronto, Ontario, Canada.
Mulligan AM; 1] Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada. [2] Laboratory Medicine Program, University Health Network, Toronto, Ontario, Canada.
Sawyer EJ; Research Oncology, Division of Cancer Studies, King's College London, Guy's Hospital, London, UK.
Tomlinson I; 1] Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, UK. [2] Oxford Biomedical Research Centre, University of Oxford, Oxford, UK.
Kerin MJ; Department of Surgery, School of Medicine, National University of Ireland, Galway, Ireland.
Miller N; Department of Surgery, School of Medicine, National University of Ireland, Galway, Ireland.
Lindblom A; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
Margolin S; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.
Teo SH; 1] Cancer Research Initiatives Foundation, Sime Darby Medical Centre, Subang Jaya, Malaysia. [2] Breast Cancer Research Unit, University Malaya Cancer Research Institute, University Malaya Medical Centre (UMMC), Kuala Lumpur, Malaysia.
Yip CH; Breast Cancer Research Unit, University Malaya Cancer Research Institute, University Malaya Medical Centre (UMMC), Kuala Lumpur, Malaysia.
Taib NA; Breast Cancer Research Unit, University Malaya Cancer Research Institute, University Malaya Medical Centre (UMMC), Kuala Lumpur, Malaysia.
Tan GH; Breast Cancer Research Unit, University Malaya Cancer Research Institute, University Malaya Medical Centre (UMMC), Kuala Lumpur, Malaysia.
Hooning MJ; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.
Hollestelle A; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.
Martens JW; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.
Collée JM; Department of Clinical Genetics, Erasmus University Medical Center, Rotterdam, the Netherlands.
Blot W; 1] Department of Medicine, Division of Epidemiology, Vanderbilt Epidemiology Center and Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee, USA. [2] International Epidemiology Institute, Rockville, Maryland, USA.
Signorello LB; Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts, USA.
Cai Q; Department of Medicine, Division of Epidemiology, Vanderbilt Epidemiology Center and Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee, USA.
Hopper JL; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, University of Melbourne, Melbourne, Victoria, Australia.
Southey MC; Department of Pathology, University of Melbourne, Melbourne, Victoria, Australia.
Tsimiklis H; Department of Pathology, University of Melbourne, Melbourne, Victoria, Australia.
Apicella C; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, University of Melbourne, Melbourne, Victoria, Australia.
Shen CY; 1] Taiwan Biobank, Institute of Biomedical Sciences, Academia Sinica, Taipei, Taiwan. [2] Institute of Biomedical Sciences, Academia Sinica, Taipei, Taiwan. [3] School of Public Health, China Medical University, Taichung, Taiwan.
Hsiung CN; Institute of Biomedical Sciences, Academia Sinica, Taipei, Taiwan.
Wu PE; 1] Taiwan Biobank, Institute of Biomedical Sciences, Academia Sinica, Taipei, Taiwan. [2] Institute of Biomedical Sciences, Academia Sinica, Taipei, Taiwan.
Hou MF; 1] Cancer Center, Kaohsiung Medical University Chung-Ho Memorial Hospital, Kaohsiung, Taiwan. [2] Department of Surgery, Kaohsiung Medical University Chung-Ho Memorial Hospital, Kaohsiung, Taiwan.
Kristensen VN; 1] Department of Genetics, Institute for Cancer Research, Oslo University Hospital, Radiumhospitalet, Oslo, Norway. [2] Institute of Clinical Medicine, University of Oslo, Oslo, Norway. [3] Department of Clinical Molecular Biology (EpiGen), University of Oslo, Oslo, Norway.
Nord S; Department of Genetics, Institute for Cancer Research, Oslo University Hospital, Radiumhospitalet, Oslo, Norway.
Alnaes GI; Department of Genetics, Institute for Cancer Research, Oslo University Hospital, Radiumhospitalet, Oslo, Norway.
Giles GG; 1] Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, University of Melbourne, Melbourne, Victoria, Australia. [2] Cancer Epidemiology Centre, Cancer Council Victoria, Melbourne, Victoria, Australia.
Milne RL; 1] Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, University of Melbourne, Melbourne, Victoria, Australia. [2] Cancer Epidemiology Centre, Cancer Council Victoria, Melbourne, Victoria, Australia.
McLean C; Department of Anatomical Pathology, Alfred Hospital, Melbourne, Victoria, Australia.
Canzian F; Genomic Epidemiology Group, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Trichopoulos D; 1] Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts, USA. [2] Bureau of Epidemiologic Research, Academy of Athens, Athens, Greece. [3] Hellenic Health Foundation, Athens, Greece.
Peeters P; 1] Department of Epidemiology, Julius Center for Health Sciences and Primary Care, University Medical Center, Utrecht, the Netherlands. [2] Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, UK.
Lund E; Department of Community Medicine, Faculty of Health Sciences, University of Tromsø, Arctic University of Norway, Tromsø, Norway.
Sund M; Department of Surgical and Perioperative Sciences, Umea University, Umea, Sweden.
Khaw KT; School of Clinical Medicine, Cambridge Institute of Public Health, University of Cambridge, Cambridge, UK.
Gunter MJ; Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, UK.
Palli D; Molecular and Nutritional Epidemiology Unit, Cancer Research and Prevention Institute, Istituto per lo Studio e la Prevenzione Oncologica (ISPO), Florence, Italy.
Mortensen LM; Section for Epidemiology, Aarhus University, Aarhus, Denmark.
Dossus L; 1] INSERM Centre for Research in Epidemiology and Population Health (CESP), U1018, Nutrition, Hormones and Women's Health Team, Villejuif, France. [2] Université Paris-Sud, Villejuif, France.
Huerta JM; Department of Epidemiology, Consejería de Sanidad y Política Social, CIBER de Epidemiología y Salud Pública, Murcia, Spain.
Meindl A; Division of Gynaecology and Obstetrics, Technische Universität München, Munich, Germany.
Schmutzler RK; 1] Center for Hereditary Breast and Ovarian Cancer, University Hospital Cologne, Cologne, Germany. [2] Center for Integrated Oncology (CIO), University Hospital Cologne, Cologne, Germany. [3] Center for Molecular Medicine Cologne (CMMC), Faculty of Medicine, University of Cologne, Cologne, Germany.
Sutter C; Institute of Human Genetics, University Hospital Heidelberg, Heidelberg, Germany.
Yang R; 1] Department of Obstetrics and Gynecology, University of Heidelberg, Heidelberg, Germany. [2] Molecular Epidemiology Group, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Muir K; 1] Division of Health Sciences, Warwick Medical School, Warwick University, Coventry, UK. [2] Institute of Population Health, University of Manchester, Manchester, UK.
Lophatananon A; Division of Health Sciences, Warwick Medical School, Warwick University, Coventry, UK.
Stewart-Brown S; Division of Health Sciences, Warwick Medical School, Warwick University, Coventry, UK.
Siriwanarangsan P; Ministry of Public Health, Nonthaburi, Thailand.
Hartman M; 1] Department of Surgery, Yong Loo Lin School of Medicine, National University of Singapore and National University Health System, Singapore. [2] Saw Swee Hock School of Public Health, National University of Singapore and National University Health System, Singapore.
Miao H; Saw Swee Hock School of Public Health, National University of Singapore and National University Health System, Singapore.
Chia KS; Saw Swee Hock School of Public Health, National University of Singapore and National University Health System, Singapore.
Chan CW; Division of General Surgery, National University Health System, Singapore.
Fasching PA; 1] Department of Gynecology and Obstetrics, University Breast Center Franconia, University Hospital Erlangen, Friedrich Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center of the Erlangen-Nuremberg Metropolitan Region, Erlangen, Germany. [2] Department of Medicine, Division of Hematology and Oncology, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California, USA.
Hein A; Department of Gynecology and Obstetrics, University Breast Center Franconia, University Hospital Erlangen, Friedrich Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center of the Erlangen-Nuremberg Metropolitan Region, Erlangen, Germany.
Beckmann MW; Department of Gynecology and Obstetrics, University Breast Center Franconia, University Hospital Erlangen, Friedrich Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center of the Erlangen-Nuremberg Metropolitan Region, Erlangen, Germany.
Haeberle L; Department of Gynecology and Obstetrics, University Breast Center Franconia, University Hospital Erlangen, Friedrich Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center of the Erlangen-Nuremberg Metropolitan Region, Erlangen, Germany.
Brenner H; 1] Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany. [2] German Cancer Consortium (DKTK), Heidelberg, Germany.
Dieffenbach AK; 1] Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany. [2] German Cancer Consortium (DKTK), Heidelberg, Germany.
Arndt V; Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Stegmaier C; Saarland Cancer Registry, Saarbrücken, Germany.
Ashworth A; Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK.
Orr N; Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK.
Schoemaker MJ; Division of Genetics and Epidemiology, Institute of Cancer Research, London, UK.
Swerdlow AJ; 1] Division of Genetics and Epidemiology, Institute of Cancer Research, London, UK. [2] Division of Breast Cancer Research, Institute of Cancer Research, London, UK.
Brinton L; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland, USA.
Garcia-Closas M; 1] Division of Genetics and Epidemiology, Institute of Cancer Research, London, UK. [2] Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK.
Zheng W; Department of Medicine, Division of Epidemiology, Vanderbilt Epidemiology Center and Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee, USA.
Halverson SL; Department of Medicine, Division of Epidemiology, Vanderbilt Epidemiology Center and Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee, USA.
Shrubsole M; Department of Medicine, Division of Epidemiology, Vanderbilt Epidemiology Center and Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee, USA.
Long J; Department of Medicine, Division of Epidemiology, Vanderbilt Epidemiology Center and Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee, USA.
Goldberg MS; 1] Department of Medicine, McGill University, Montreal, Quebec, Canada. [2] Division of Clinical Epidemiology, McGill University Health Centre, Royal Victoria Hospital, Montreal, Quebec, Canada.
Labrèche F; 1] Département de Santé Environnementale et Santé au Travail, Ecole de Santé Publique, Université de Montréal, Montreal, Quebec, Canada. [2] Département de Médecine Sociale et Préventive, Ecole de Santé Publique, Université de Montréal, Montreal, Quebec, Canada.
Dumont M; 1] Centre Hospitalier Universitaire de Québec Research Center, Quebec City, Quebec, Canada. [2] Department of Molecular Medicine, Laval University, Quebec City, Quebec, Canada.
Winqvist R; Laboratory of Cancer Genetics and Tumor Biology, Department of Clinical Chemistry and Biocenter Oulu, University of Oulu, NordLab Oulu/Oulu University Hospital, Oulu, Finland.
Pylkäs K; Laboratory of Cancer Genetics and Tumor Biology, Department of Clinical Chemistry and Biocenter Oulu, University of Oulu, NordLab Oulu/Oulu University Hospital, Oulu, Finland.
Jukkola-Vuorinen A; Department of Oncology, Oulu University Hospital, University of Oulu, Oulu, Finland.
Grip M; Department of Surgery, Oulu University Hospital, University of Oulu, Oulu, Finland.
Brauch H; 1] German Cancer Consortium (DKTK), Heidelberg, Germany. [2] Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, Germany. [3] University of Tübingen, Tübingen, Germany. [4] German Cancer Research Center (DKFZ), Heidelberg, Germany.
Hamann U; Molecular Genetics of Breast Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Brüning T; Institute for Prevention and Occupational Medicine of the German Social Accident Insurance, Institute of the Ruhr University Bochum (IPA), Bochum, Germany.
Radice P; Unit of Molecular Bases of Genetic Risk and Genetic Testing, Department of Preventive and Predictive Medicine, Fondazione IRCCS (Istituto di Ricovero e Cura a Carattere Scientifico) Istituto Nazionale Tumori (INT), Milan, Italy.
Peterlongo P; Fondazione Istituto FIRC (Italian Foundation for Cancer Research) di Oncologia Molecolare (IFOM), Milan, Italy.
Manoukian S; Unit of Medical Genetics, Department of Preventive and Predictive Medicine, Fondazione IRCCS (Istituto di Ricovero e Cura a Carattere Scientifico) Istituto Nazionale Tumori (INT), Milan, Italy.
Bernard L; 1] Department of Experimental Oncology, Istituto Europeo di Oncologia, Milan, Italy. [2] Cogentech Cancer Genetic Test Laboratory, Milan, Italy.
Bogdanova NV; Department of Radiation Oncology, Hannover Medical School, Hannover, Germany.
Dörk T; Gynaecology Research Unit, Hannover Medical School, Hannover, Germany.
Mannermaa A; 1] School of Medicine, Institute of Clinical Medicine, Pathology and Forensic Medicine, University of Eastern Finland, Kuopio, Finland. [2] Cancer Center of Eastern Finland, University of Eastern Finland, Kuopio, Finland. [3] Imaging Center, Department of Clinical Pathology, Kuopio University Hospital, Kuopio, Finland.
Kataja V; 1] Cancer Center, Kuopio University Hospital, Kuopio, Finland. [2] Central Finland Hospital District, Jyväskylä Central Hospital, Jyväskylä, Finland.
Kosma VM; 1] School of Medicine, Institute of Clinical Medicine, Pathology and Forensic Medicine, University of Eastern Finland, Kuopio, Finland. [2] Cancer Center of Eastern Finland, University of Eastern Finland, Kuopio, Finland. [3] Imaging Center, Department of Clinical Pathology, Kuopio University Hospital, Kuopio, Finland.
Hartikainen JM; 1] School of Medicine, Institute of Clinical Medicine, Pathology and Forensic Medicine, University of Eastern Finland, Kuopio, Finland. [2] Cancer Center of Eastern Finland, University of Eastern Finland, Kuopio, Finland. [3] Imaging Center, Department of Clinical Pathology, Kuopio University Hospital, Kuopio, Finland.
Devilee P; 1] Department of Human Genetics, Leiden University Medical Center, Leiden, the Netherlands. [2] Department of Pathology, Leiden University Medical Center, Leiden, the Netherlands.
Tollenaar RA; Department of Surgical Oncology, Leiden University Medical Center, Leiden, the Netherlands.
Seynaeve C; Department of Medical Oncology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.
Van Asperen CJ; Department of Clinical Genetics, Leiden University Medical Center, Leiden, the Netherlands.
Jakubowska A; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland.
Lubinski J; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland.
Jaworska K; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland.
Huzarski T; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland.
Sangrajrang S; National Cancer Institute of Thailand, Bangkok, Thailand.
Gaborieau V; International Agency for Research on Cancer, Lyon, France.
Brennan P; International Agency for Research on Cancer, Lyon, France.
McKay J; International Agency for Research on Cancer, Lyon, France.
Slager S; Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota, USA.
Toland AE; Department of Molecular Virology, Immunology and Medical Genetics, Ohio State University, Columbus, Ohio, USA.
Ambrosone CB; Roswell Park Cancer Institute, Buffalo, New York, USA.
Yannoukakos D; Molecular Diagnostics Laboratory, Institute of Radioisotopes and Radiodiagnostic Products (IRRP), National Centre for Scientific Research 'Demokritos', Aghia Paraskevi Attikis, Athens, Greece.
Kabisch M; Molecular Genetics of Breast Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Torres D; 1] Molecular Genetics of Breast Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany. [2] Institute of Human Genetics, Pontificia Universidad Javeriana, Bogotá, Colombia.
Neuhausen SL; Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, California, USA.
Anton-Culver H; Department of Epidemiology, University of California-Irvine, Irvine, California, USA.
Luccarini C; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK.
Baynes C; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK.
Ahmed S; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK.
Healey CS; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK.
Tessier DC; McGill University and Génome Québec Innovation Centre, Montreal, Quebec, Canada.
Vincent D; McGill University and Génome Québec Innovation Centre, Montreal, Quebec, Canada.
Bacot F; McGill University and Génome Québec Innovation Centre, Montreal, Quebec, Canada.
Pita G; Human Genotyping (CEGEN) Unit, Human Cancer Genetics Program, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.
Alonso MR; Human Genotyping (CEGEN) Unit, Human Cancer Genetics Program, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.
Álvarez N; Human Genotyping (CEGEN) Unit, Human Cancer Genetics Program, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.
Herrero D; Human Genotyping (CEGEN) Unit, Human Cancer Genetics Program, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.
Simard J; 1] Centre Hospitalier Universitaire de Québec Research Center, Quebec City, Quebec, Canada. [2] Department of Molecular Medicine, Laval University, Quebec City, Quebec, Canada.
Pharoah PP; 1] Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK. [2] Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK.
Kraft P; Program in Genetic Epidemiology and Statistical Genetics, Harvard School of Public Health, Boston, Massachusetts, USA.
Dunning AM; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK.
Chenevix-Trench G; Department of Genetics, QIMR (Queensland Institute for Medical Research) Berghofer Medical Research Institute, Brisbane, Queensland, Australia.
Hall P; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
Easton DF; 1] Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK. [2] Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK.; Pokaż więcej
Corporate Authors:: BOCS
kConFab Investigators
AOCS Group
NBCS
GENICA Network
Źródło:: Nature genetics [Nat Genet] 2015 Apr; Vol. 47 (4), pp. 373-80. Date of Electronic Publication: 2015 Mar 09.
Typ publikacji:: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:: Genetic Loci*
Genetic Predisposition to Disease*
Breast Neoplasms/*genetics
Case-Control Studies ; Cohort Studies ; Female ; Genome-Wide Association Study ; Humans ; Meta-Analysis as Topic ; Microarray Analysis ; Polymorphism, Single Nucleotide

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 11.

Tytuł:: MicroRNA related polymorphisms and breast cancer risk.
Autorzy:: Khan S; Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland.
Greco D; Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland; Finnish Institute of Occupational Health, Helsinki, Finland.
Michailidou K; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom.
Milne RL; Cancer Epidemiology Centre, Cancer Council Victoria, Melbourne, Australia; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Australia.
Muranen TA; Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland.
Heikkinen T; Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland.
Aaltonen K; Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland; Department of Clinical Genetics, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland; Department of Oncology, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland.
Dennis J; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom.
Bolla MK; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom.
Liu J; Human Genetics Division, Genome Institute of Singapore, Singapore, Singapore.
Hall P; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
Irwanto A; Human Genetics Division, Genome Institute of Singapore, Singapore, Singapore.
Humphreys K; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
Li J; Human Genetics Division, Genome Institute of Singapore, Singapore, Singapore.
Czene K; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
Chang-Claude J; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Hein R; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany; PMV Research Group at the Department of Child and Adolescent Psychiatry and Psychotherapy, University of Cologne, Cologne, Germany.
Rudolph A; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Seibold P; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Flesch-Janys D; Department of Cancer Epidemiology/Clinical Cancer Registry and Institute for Medical Biometrics and Epidemiology, University Clinic Hamburg-Eppendorf, Hamburg, Germany.
Fletcher O; Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, United Kingdom.
Peto J; Department of Non-Communicable Disease Epidemiology Department, London School of Hygiene and Tropical Medicine, London, United Kingdom.
dos Santos Silva I; Department of Non-Communicable Disease Epidemiology Department, London School of Hygiene and Tropical Medicine, London, United Kingdom.
Johnson N; Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, United Kingdom.
Gibson L; Department of Non-Communicable Disease Epidemiology Department, London School of Hygiene and Tropical Medicine, London, United Kingdom.
Aitken Z; Department of Non-Communicable Disease Epidemiology Department, London School of Hygiene and Tropical Medicine, London, United Kingdom.
Hopper JL; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Australia.
Tsimiklis H; Department of Pathology, The University of Melbourne, Melbourne, Australia.
Bui M; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Australia.
Makalic E; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Australia.
Schmidt DF; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Australia.
Southey MC; Department of Pathology, The University of Melbourne, Melbourne, Australia.
Apicella C; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Australia.
Stone J; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Australia.
Waisfisz Q; Department of Clinical Genetics, VU University Medical Center, Amsterdam, The Netherlands.
Meijers-Heijboer H; Department of Clinical Genetics, VU University Medical Center, Amsterdam, The Netherlands.
Adank MA; Department of Clinical Genetics, VU University Medical Center, Amsterdam, The Netherlands.
van der Luijt RB; Department of Medical Genetics, University Medical Center Utrecht, Utrecht, The Netherlands.
Meindl A; Division of Gynaecology and Obstetrics, Technische Universität München, Munich, Germany.
Schmutzler RK; Division of Molecular Gyneco-Oncology, Department of Gynaecology and Obstetrics, University Hospital of Cologne, Cologne, Germany; Center of Familial Breast and Ovarian Cancer, University Hospital of Cologne, Cologne, Germany; Center for Integrated Oncology (CIO), University Hospital of Cologne, Cologne, Germany; Center for Molecular Medicine Cologne (CMMC), University of Cologne, Cologne, Germany.
Müller-Myhsok B; Max Planck Institute of Psychiatry, Munich, Germany.
Lichtner P; Institute of Human Genetics, Helmholtz Zentrum München, German Research Center for Environmental Health, Neuherberg, Germany.
Turnbull C; Section of Cancer Genetics, Institute of Cancer Research, Sutton, United Kingdom.
Rahman N; Section of Cancer Genetics, Institute of Cancer Research, Sutton, United Kingdom.
Chanock SJ; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland, United States of America.
Hunter DJ; Program in Molecular and Genetic Epidemiology, Harvard School of Public Health, Boston, Massachusetts, United States of America; Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts, United States of America.
Cox A; CRUK/YCR Sheffield Cancer Research Centre, Department of Oncology, University of Sheffield, Sheffield, United Kingdom.
Cross SS; Academic Unit of Pathology, Department of Neuroscience, University of Sheffield, Sheffield, United Kingdom.
Reed MW; CRUK/YCR Sheffield Cancer Research Centre, Department of Oncology, University of Sheffield, Sheffield, United Kingdom.
Schmidt MK; Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, The Netherlands.
Broeks A; Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, The Netherlands.
Van't Veer LJ; Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, The Netherlands.
Hogervorst FB; Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, The Netherlands.
Fasching PA; University Breast Center Franconia, Department of Gynecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Cancer Erlangen-EMN, Erlangen, Germany; David Geffen School of Medicine, Department of Medicine Division of Hematology and Oncology, University of California Los Angeles, California, United States of America.
Schrauder MG; University Breast Center Franconia, Department of Gynecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Cancer Erlangen-EMN, Erlangen, Germany.
Ekici AB; Institute of Human Genetics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-EMN, Erlangen, Germany.
Beckmann MW; University Breast Center Franconia, Department of Gynecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Cancer Erlangen-EMN, Erlangen, Germany.
Bojesen SE; Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark; Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark.
Nordestgaard BG; Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark; Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark.
Nielsen SF; Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark; Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark.
Flyger H; Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark.
Benitez J; Human Genetics Group, Human Cancer Genetics Program, Spanish National Cancer Research Centre (CNIO), Madrid, Spain; Centro de Investigación en Red de Enfermedades Raras (CIBERER), Valencia, Spain.
Zamora PM; Servicio de Oncología Médica, Hospital Universitario La Paz, Madrid, Spain.
Perez JI; Servicio de Cirugía General y Especialidades, Hospital Monte Naranco, Oviedo, Spain.
Haiman CA; Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California, United States of America.
Henderson BE; Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California, United States of America.
Schumacher F; Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California, United States of America.
Le Marchand L; Epidemiology Program, Cancer Research Center, University of Hawaii, Honolulu, Hawaii, United States of America.
Pharoah PD; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, United Kingdom.
Dunning AM; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, United Kingdom.
Shah M; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, United Kingdom.
Luben R; Clinical Gerontology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom.
Brown J; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom.
Couch FJ; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, United States of America.
Wang X; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, United States of America.
Vachon C; Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota, United States of America.
Olson JE; Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota, United States of America.
Lambrechts D; Vesalius Research Center (VRC), VIB, Leuven, Belgium; Laboratory for Translational Genetics, Department of Oncology, University of Leuven, Leuven, Belgium.
Moisse M; Vesalius Research Center (VRC), VIB, Leuven, Belgium; Laboratory for Translational Genetics, Department of Oncology, University of Leuven, Leuven, Belgium.
Paridaens R; Oncology Department, University Hospital Gasthuisberg, Leuven, Belgium.
Christiaens MR; Oncology Department, University Hospital Gasthuisberg, Leuven, Belgium.
Guénel P; Inserm (National Institute of Health and Medical Research), CESP (Center for Research in Epidemiology and Population Health), U1018, Environmental Epidemiology of Cancer, Villejuif, France; University Paris-Sud, UMRS 1018, Villejuif, France.
Truong T; Inserm (National Institute of Health and Medical Research), CESP (Center for Research in Epidemiology and Population Health), U1018, Environmental Epidemiology of Cancer, Villejuif, France; University Paris-Sud, UMRS 1018, Villejuif, France.
Laurent-Puig P; Université Paris Sorbonne Cité, UMR-S775 Inserm, Paris, France.
Mulot C; Université Paris Sorbonne Cité, UMR-S775 Inserm, Paris, France.
Marme F; Department of Obstetrics and Gynecology, University of Heidelberg, Heidelberg, Germany; National Center for Tumor Diseases, University of Heidelberg, Heidelberg, Germany.
Burwinkel B; Department of Obstetrics and Gynecology, University of Heidelberg, Heidelberg, Germany; Molecular Epidemiology Group, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Schneeweiss A; Department of Obstetrics and Gynecology, University of Heidelberg, Heidelberg, Germany; National Center for Tumor Diseases, University of Heidelberg, Heidelberg, Germany.
Sohn C; Department of Obstetrics and Gynecology, University of Heidelberg, Heidelberg, Germany.
Sawyer EJ; Research Oncology, Division of Cancer Studies, King's College London, Guy's Hospital, London, United Kingdom.
Tomlinson I; Wellcome Trust Centre for Human Genetics and Oxford Biomedical Research Centre, University of Oxford, Oxford, United Kingdom.
Kerin MJ; Clinical Science Institute, University Hospital Galway, Galway, Ireland.
Miller N; Clinical Science Institute, University Hospital Galway, Galway, Ireland.
Andrulis IL; Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Toronto, Ontario, Canada; Department of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada.
Knight JA; Prosserman Centre for Health Research, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada; Division of Epidemiology, Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada.
Tchatchou S; Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Toronto, Ontario, Canada.
Mulligan AM; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada; Department of Laboratory Medicine, and the Keenan Research Centre of the Li Ka Shing Knowledge Institute, St Michael's Hospital, Toronto, Ontario, Canada.
Dörk T; Department of Obstetrics and Gynaecology, Hannover Medical School, Hannover, Germany.
Bogdanova NV; Department of Radiation Oncology, Hannover Medical School, Hannover, Germany.
Antonenkova NN; N.N. Alexandrov Research Institute of Oncology and Medical Radiology, Minsk, Belarus.
Anton-Culver H; Department of Epidemiology, University of California Irvine, Irvine, California, United States of America.
Darabi H; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
Eriksson M; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
Garcia-Closas M; Division of Genetics and Epidemiology, Institute of Cancer Research, Sutton, United Kingdom; Breakthrough Breast Cancer Research Centre, Division of Breast Cancer Research, The Institute of Cancer Research, London, United Kingdom.
Figueroa J; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland, United States of America.
Lissowska J; Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland.
Brinton L; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland, United States of America.
Devilee P; Department of Human Genetics & Department of Pathology, Leiden University Medical Center, Leiden, Netherlands.
Tollenaar RA; Department of Surgical Oncology, Leiden University Medical Center, Leiden, Netherlands.
Seynaeve C; Family Cancer Clinic, Department of Medical Oncology, Erasmus MC-Daniel den Hoed Cancer Center, Rotterdam, Netherlands.
van Asperen CJ; Department of Clinical Genetics, Leiden University Medical Center, Leiden, Netherlands.
Kristensen VN; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway; Department of Clinical Molecular Biology (EpiGen), University of Oslo, Oslo, Norway; Department of Genetics, Institute for Cancer Research, Oslo University Hospital, Radiumhospitalet, Oslo, Norway.
Slager S; Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota, United States of America.
Toland AE; Department of Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio, United States of America.
Ambrosone CB; Roswell Park Cancer Institute, Buffalo, New York, United States of America.
Yannoukakos D; Molecular Diagnostics Laboratory, IRRP, National Centre for Scientific Research 'Demokritos', Aghia Paraskevi Attikis, Athens, Greece.
Lindblom A; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
Margolin S; Department of Oncology - Pathology, Karolinska Institutet, Stockholm, Sweden.
Radice P; Unit of Molecular Bases of Genetic Risk and Genetic Testing, Department of Preventive and Predictive Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori (INT), Milan, Italy.
Peterlongo P; IFOM, Fondazione Istituto FIRC di Oncologia Molecolare, Milan, Italy.
Barile M; Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia (IEO), Milan, Italy.
Mariani P; IFOM, Fondazione Istituto FIRC di Oncologia Molecolare, Milan, Italy; Cogentech Cancer Genetic Test Laboratory, Milan, Italy.
Hooning MJ; Department of Medical Oncology, Erasmus University Medical Center, Rotterdam, The Netherlands.
Martens JW; Department of Medical Oncology, Erasmus University Medical Center, Rotterdam, The Netherlands.
Collée JM; Department of Clinical Genetics, Erasmus University Medical Center, Rotterdam, The Netherlands.
Jager A; Department of Medical Oncology, Erasmus University Medical Center, Rotterdam, The Netherlands.
Jakubowska A; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland.
Lubinski J; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland.
Jaworska-Bieniek K; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland; Postgraduate School of Molecular Medicine, Warsaw Medical University, Warsaw, Poland.
Durda K; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland.
Giles GG; Cancer Epidemiology Centre, Cancer Council Victoria, Melbourne, Australia; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Australia.
McLean C; Anatomical Pathology, The Alfred Hospital, Melbourne, Australia.
Brauch H; Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology, Stuttgart, Germany; University of Tübingen, Tübingen, Germany.
Brüning T; Institute for Prevention and Occupational Medicine of the German Social Accident Insurance, Institute of the Ruhr-University Bochum (IPA), Bochum, Germany.
Ko YD; Department of Internal Medicine, Evangelische Kliniken Bonn gGmbH, Johanniter Krankenhaus, Bonn, Germany.
Brenner H; Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany; German Cancer Consortium (DKTK), Heidelberg, Germany.
Dieffenbach AK; Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany; German Cancer Consortium (DKTK), Heidelberg, Germany.
Arndt V; Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Stegmaier C; Saarland Cancer Registry, Saarbrücken, Germany.
Swerdlow A; Division of Genetics and Epidemiology and Division of Breast Cancer Research, The Institute of Cancer Research, Sutton, Surrey, United Kingdom.
Ashworth A; Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, United Kingdom.
Orr N; Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, United Kingdom.
Jones M; Division of Genetics and Epidemiology, Institute of Cancer Research, Sutton, United Kingdom.
Simard J; Cancer Genomics Laboratory, Centre Hospitalier Universitaire de Québec Research Center and Laval University, Quebec, Canada.
Goldberg MS; Department of Medicine, McGill University, Montreal, Canada; Division of Clinical Epidemiology, McGill University Health Centre, Royal Victoria Hospital, Montreal, Quebec, Canada.
Labrèche F; Départements de Santé Environnementale et Santé au Travail et de Médecine Sociale et Préventive, Université de Montréal, Montreal, Quebec, Canada.
Dumont M; Cancer Genomics Laboratory, Centre Hospitalier Universitaire de Québec Research Center and Laval University, Quebec, Canada.
Winqvist R; Laboratory of Cancer Genetics and Tumor Biology, Department of Clinical Chemistry and Biocenter Oulu, University of Oulu, NordLab Oulu/Oulu University Hospital, Oulu, Finland.
Pylkäs K; Laboratory of Cancer Genetics and Tumor Biology, Department of Clinical Chemistry and Biocenter Oulu, University of Oulu, NordLab Oulu/Oulu University Hospital, Oulu, Finland.
Jukkola-Vuorinen A; Department of Oncology, Oulu University Hospital, University of Oulu, Oulu, Finland.
Grip M; Department of Surgery, Oulu University Hospital, University of Oulu, Oulu, Finland.
Kataja V; School of Medicine, Institute of Clinical Medicine, Oncology, University of Eastern Finland, Kuopio, Finland; Cancer Center, Kuopio University Hospital, Kuopio, Finland.
Kosma VM; School of Medicine, Institute of Clinical Medicine, Pathology and Forensic Medicine, University of Eastern Finland, Kuopio, Finland; Imaging Center, Department of Clinical Pathology, Kuopio University Hospital, Kuopio, Finland; Cancer Center of Eastern Finland, University of Eastern Finland, Kuopio, Finland.
Hartikainen JM; School of Medicine, Institute of Clinical Medicine, Pathology and Forensic Medicine, University of Eastern Finland, Kuopio, Finland; Imaging Center, Department of Clinical Pathology, Kuopio University Hospital, Kuopio, Finland; Cancer Center of Eastern Finland, University of Eastern Finland, Kuopio, Finland.
Mannermaa A; School of Medicine, Institute of Clinical Medicine, Pathology and Forensic Medicine, University of Eastern Finland, Kuopio, Finland; Imaging Center, Department of Clinical Pathology, Kuopio University Hospital, Kuopio, Finland; Cancer Center of Eastern Finland, University of Eastern Finland, Kuopio, Finland.
Hamann U; Molecular Genetics of Breast Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Chenevix-Trench G; Department of Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia.
Blomqvist C; Department of Oncology, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland.
Aittomäki K; Department of Clinical Genetics, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland.
Easton DF; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, United Kingdom.
Nevanlinna H; Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland.; Pokaż więcej
Corporate Authors:: kConFab Investigators
Australian Ovarian Cancer Study Group
GENICA Network
Źródło:: PloS one [PLoS One] 2014 Nov 12; Vol. 9 (11), pp. e109973. Date of Electronic Publication: 2014 Nov 12 (Print Publication: 2014).
Typ publikacji:: Journal Article; Research Support, N.I.H., Extramural; Research Support, N.I.H., Intramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
MeSH Terms:: Polymorphism, Single Nucleotide*
Breast Neoplasms/*diagnosis
Breast Neoplasms/*genetics
MicroRNAs/*genetics
3' Untranslated Regions ; Binding Sites ; Case-Control Studies ; Chromosome Mapping ; Computational Biology ; Female ; Genome-Wide Association Study ; Genotype ; Humans ; Receptors, Estrogen/metabolism

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 12.

Tytuł:: Genetic predisposition to in situ and invasive lobular carcinoma of the breast.
Autorzy:: Sawyer E; Research Oncology, Division of Cancer Studies, Kings College London, Guy's Hospital, London, United Kingdom.
Roylance R; Centre for Molecular Oncology, Barts Cancer Institute, Queen Mary University of London, London, United Kingdom.
Petridis C; Research Oncology, Division of Cancer Studies, Kings College London, Guy's Hospital, London, United Kingdom.
Brook MN; Division of Genetics and Epidemiology, Institute of Cancer Research, London, United Kingdom.
Nowinski S; Research Oncology, Division of Cancer Studies, Kings College London, Guy's Hospital, London, United Kingdom.
Papouli E; Biomedical Research Centre, King's College London, Guy's Hospital, London, United Kingdom.
Fletcher O; Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, United Kingdom.
Pinder S; Research Oncology, Division of Cancer Studies, Kings College London, Guy's Hospital, London, United Kingdom.
Hanby A; Leeds Institute of Molecular Medicine, St James's University Hospital, Leeds, United Kingdom.
Kohut K; Centre for Molecular Oncology, Barts Cancer Institute, Queen Mary University of London, London, United Kingdom.
Gorman P; Centre for Molecular Oncology, Barts Cancer Institute, Queen Mary University of London, London, United Kingdom.
Caneppele M; Centre for Molecular Oncology, Barts Cancer Institute, Queen Mary University of London, London, United Kingdom.
Peto J; London School of Hygiene and Tropical Medicine, London, United Kingdom.
Dos Santos Silva I; London School of Hygiene and Tropical Medicine, London, United Kingdom.
Johnson N; Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, United Kingdom.
Swann R; Department of Molecular and Applied Biosciences, University of Westminster, London, United Kingdom.
Dwek M; Department of Molecular and Applied Biosciences, University of Westminster, London, United Kingdom.
Perkins KA; Department of Molecular and Applied Biosciences, University of Westminster, London, United Kingdom.
Gillett C; Research Oncology, Division of Cancer Studies, Kings College London, Guy's Hospital, London, United Kingdom.
Houlston R; Division of Genetics and Epidemiology, Institute of Cancer Research, London, United Kingdom.
Ross G; The Royal Marsden NHS Foundation Trust, London, United Kingdom.
De Ieso P; The Royal Marsden NHS Foundation Trust, London, United Kingdom.
Southey MC; Department of Pathology, The University of Melbourne, Melbourne, Australia.
Hopper JL; Centre for Molecular, Environmental, Genetic and Analytic Epidemiology, The University of Melbourne, Melbourne, Australia.
Provenzano E; NIHR Cambridge Biomedical Research Centre, Addenbrookes Hospital, Cambridge, United Kingdom.
Apicella C; Centre for Molecular, Environmental, Genetic and Analytic Epidemiology, The University of Melbourne, Melbourne, Australia.
Wesseling J; Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.
Cornelissen S; Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.
Keeman R; Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.
Fasching PA; David Geffen School of Medicine, Department of Medicine Division of Hematology and Oncology, University of California at Los Angeles, Los Angeles, California, United States of America; Department of Gynecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Comprehensive Cancer Center Erlangen-EMN, Erlangen, Germany.
Jud SM; Department of Gynecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Comprehensive Cancer Center Erlangen-EMN, Erlangen, Germany.
Ekici AB; Institute of Human Genetics, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.
Beckmann MW; Department of Gynecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Comprehensive Cancer Center Erlangen-EMN, Erlangen, Germany.
Kerin MJ; Surgery, Clinical Science Institute, National University of Ireland, Galway, Ireland.
Marme F; Department of Obstetrics and Gynecology, University of Heidelberg, Heidelberg, Germany; National Center for Tumor Diseases, University of Heidelberg, Heidelberg, Germany.
Schneeweiss A; Department of Obstetrics and Gynecology, University of Heidelberg, Heidelberg, Germany; National Center for Tumor Diseases, University of Heidelberg, Heidelberg, Germany.
Sohn C; Department of Obstetrics and Gynecology, University of Heidelberg, Heidelberg, Germany.
Burwinkel B; Department of Obstetrics and Gynecology, University of Heidelberg, Heidelberg, Germany; Molecular Epidemiology Group, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Guénel P; Inserm (National Institute of Health and Medical Research), CESP (Center for Research in Epidemiology and Population Health), U1018, Environmental Epidemiology of Cancer, Villejuif, France; University Paris-Sud, UMRS 1018, Villejuif, France.
Truong T; Inserm (National Institute of Health and Medical Research), CESP (Center for Research in Epidemiology and Population Health), U1018, Environmental Epidemiology of Cancer, Villejuif, France; University Paris-Sud, UMRS 1018, Villejuif, France.
Laurent-Puig P; Université Paris Sorbonne Cité, UMR-S775 Inserm, Paris, France.
Kerbrat P; Centre Eugène Marquis, Department of Medical Oncology, Rennes, France.
Bojesen SE; Copenhagen General Population Study and Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, University of Copenhagen, Copenhagen, Denmark.
Nordestgaard BG; Copenhagen General Population Study and Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, University of Copenhagen, Copenhagen, Denmark.
Nielsen SF; Copenhagen General Population Study and Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, University of Copenhagen, Copenhagen, Denmark.
Flyger H; Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark.
Milne RL; Genetic & Molecular Epidemiology Group, Human Cancer Genetics Program, Spanish National Cancer Research Centre [CNIO], Madrid, Spain.
Perez JI; Servicio de Cirugía General y Especialidades, Hospital Monte Naranco, Oviedo, Spain.
Menéndez P; Servicio de Anatomía Patológica, Hospital Monte Naranco, Oviedo, Spain.
Benitez J; Human Genetics Group, Human Cancer Genetics Program, Spanish National Cancer Research Centre [CNIO], Madrid, Spain.
Brenner H; Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Dieffenbach AK; Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Arndt V; Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Stegmaier C; Saarland Cancer Registry, Saarbrücken, Germany.
Meindl A; Division of Gynaecology and Obstetrics, Technische Universität München, Munich, Germany.
Lichtner P; Institute of Human Genetics, Technische Universität, Munich, Germany.
Schmutzler RK; Centre for Familial Breast and Ovarian Cancer and Centre for Integrated Oncology, University Hospital Cologne, Cologne, Germany.
Lochmann M; Division of Gynaecology and Obstetrics, Technische Universität München, Munich, Germany.
Brauch H; Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology, Stuttgart, Germany; University of Tübingen, Tübingen, Germany.
Fischer HP; Institute of Pathology, Medical Faculty of the University of Bonn, Bonn, Germany.
Ko YD; Department of Internal Medicine, Evangelische Kliniken Bonn gGmbH, Johanniter Krankenhaus, Bonn, Germany.
Nevanlinna H; Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland.
Muranen TA; Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland.
Aittomäki K; Department of Clinical Genetics, Helsinki University Central Hospital, Helsinki, Finland.
Blomqvist C; Department of Oncology, Helsinki University Central Hospital, Helsinki, Finland.
Bogdanova NV; Department of Radiation Oncology, Hannover Medical School, Hannover, Germany.
Dörk T; Gynaecology Research Unit, Hannover Medical School, Hannover, Germany.
Lindblom A; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
Margolin S; Department of Oncology - Pathology, Karolinska Institutet, Stockholm, Sweden.
Mannermaa A; School of Medicine, Institute of Clinical Medicine, Pathology and Forensic Medicine, University of Eastern Finland, Joensuu, Finland; Cancer Center, Kuopio University Hospital, Kuopio, Finland.
Kataja V; School of Medicine, Institute of Clinical Medicine, Pathology and Forensic Medicine, University of Eastern Finland, Joensuu, Finland; Cancer Center, Kuopio University Hospital, Kuopio, Finland.
Kosma VM; School of Medicine, Institute of Clinical Medicine, Pathology and Forensic Medicine, University of Eastern Finland, Joensuu, Finland; Cancer Center, Kuopio University Hospital, Kuopio, Finland.
Hartikainen JM; School of Medicine, Institute of Clinical Medicine, Pathology and Forensic Medicine, University of Eastern Finland, Joensuu, Finland; Cancer Center, Kuopio University Hospital, Kuopio, Finland.
Chenevix-Trench G; Department of Genetics, QIMR Berghofer Institute of Medical Research, Brisbane, Australia.
Lambrechts D; Vesalius Research Center (VRC), VIB, Leuven, Belgium; Department of Oncology, University of Leuven, Leuven, Belgium.
Weltens C; University Hospital Gashuisberg, Leuven, Belgium.
Van Limbergen E; University Hospital Gashuisberg, Leuven, Belgium.
Hatse S; University Hospital Gashuisberg, Leuven, Belgium.
Chang-Claude J; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Rudolph A; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Seibold P; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Flesch-Janys D; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Radice P; Unit of Molecular Bases of Genetic Risk and Genetic Testing, Preventive and Predictive Medicine, Fondazione IRCCS Istituto Nazionale Tumori (INT), Milan, Italy; IFOM, Fondazione Istituto FIRC di Oncologia Molecolare, Milan, Italy.
Peterlongo P; IFOM, Fondazione Istituto FIRC di Oncologia Molecolare, Milan, Italy.
Bonanni B; Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia (IEO), Milan, Italy.
Volorio S; IFOM, Fondazione Istituto FIRC di Oncologia Molecolare and Cogentech Cancer Genetic Test Laboratory, Milan, Italy.
Giles GG; Cancer Epidemiology Centre, The Cancer Council Victoria, Melbourne, Australia; Centre for Molecular, Environmental, Genetic, and Analytic Epidemiology, The University of Melbourne, Melbourne, Australia.
Severi G; Cancer Epidemiology Centre, The Cancer Council Victoria, Melbourne, Australia; Centre for Molecular, Environmental, Genetic, and Analytic Epidemiology, The University of Melbourne, Melbourne, Australia.
Baglietto L; Cancer Epidemiology Centre, The Cancer Council Victoria, Melbourne, Australia; Centre for Molecular, Environmental, Genetic, and Analytic Epidemiology, The University of Melbourne, Melbourne, Australia.
McLean CA; Department of Pathology, The Alfred Hospital, Prahran, Victoria, Australia.
Haiman CA; Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California, United States of America.
Henderson BE; Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California, United States of America.
Schumacher F; Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California, United States of America.
Le Marchand L; Epidemiology Program, Cancer Research Center, University of Hawaii, Honolulu, Hawaii, United States of America.
Simard J; Cancer Genomics Laboratory, Centre Hospitalier Universitaire de Québec Research Center and Laval University, Quebec, Canada.
Goldberg MS; Department of Medicine, McGill University, Montreal, Quebec, Canada; Division of Clinical Epidemiology, McGill University Health Centre, Royal Victoria Hospital, Montreal, Quebec, Canada.
Labrèche F; Département de médecine sociale et préventive, Département de santé environnementale et santé au travail, Université de Montréal, Montreal, Quebec, Canada.
Dumont M; Cancer Genomics Laboratory, Centre Hospitalier Universitaire de Québec Research Center and Laval University, Quebec, Canada.
Kristensen V; Department of Genetics, Institute for Cancer Research, Oslo University Hospital, Radiumhospitalet, Oslo, Norway; Faculty of Medicine (Faculty Division Ahus), UiO, Oslo, Norway.
Winqvist R; Laboratory of Cancer Genetics and Tumor Biology, Department of Clinical Chemistry and Biocenter Oulu, University of Oulu, NordLab/Oulu University Hospital, Oulu, Finland.
Pylkäs K; Laboratory of Cancer Genetics and Tumor Biology, Department of Clinical Chemistry and Biocenter Oulu, University of Oulu, NordLab/Oulu University Hospital, Oulu, Finland.
Jukkola-Vuorinen A; Department of Oncology, Oulu University Hospital, University of Oulu, Oulu, Finland.
Kauppila S; Department of Oncology, Oulu University Hospital, University of Oulu, Oulu, Finland.
Andrulis IL; Ontario Cancer Genetics Network, Fred A. Litwin Center for Cancer Genetics, Samuel Lunenfeld Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada; Department of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada.
Knight JA; Samuel Lunenfeld Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada; Division of Epidemiology, Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada.
Glendon G; Ontario Cancer Genetics Network, Fred A. Litwin Center for Cancer Genetics, Samuel Lunenfeld Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada.
Mulligan AM; Laboratory Medicine Program, University Health Network, Toronto, Ontario; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada.
Devillee P; Department of Human Genetics & Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands.
Tollenaar RA; Department of Surgical Oncology, Leiden University Medical Center, Leiden, The Netherlands.
Seynaeve CM; Family Cancer Clinic, Department of Medical Oncology, Erasmus MC-Daniel den Hoed Cancer Center, Rotterdam, The Netherlands.
Kriege M; Family Cancer Clinic, Department of Medical Oncology, Erasmus MC-Daniel den Hoed Cancer Center, Rotterdam, The Netherlands.
Figueroa J; Division of Cancer Prevention, National Cancer Institute, Bethesda, Maryland, United States of America.
Chanock SJ; Division of Cancer Prevention, National Cancer Institute, Bethesda, Maryland, United States of America.
Sherman ME; Division of Cancer Prevention, National Cancer Institute, Bethesda, Maryland, United States of America.
Hooning MJ; Department of Medical Oncology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
Hollestelle A; Department of Medical Oncology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
van den Ouweland AM; Department of Clinical Genetics, Erasmus University Medical Center, Rotterdam, The Netherlands.
van Deurzen CH; Department of Pathology, Erasmus University Medical Center, Rotterdam, The Netherlands.
Li J; Human Genetics Division, Genome Institute of Singapore, Singapore.
Czene K; Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
Humphreys K; Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
Cox A; CRUK/YCR Sheffield Cancer Research Centre, Department of Oncology, University of Sheffield, Sheffield, United Kingdom.
Cross SS; Academic Unit of Pathology, Department of Neuroscience, University of Sheffield, Sheffield, United Kingdom.
Reed MW; CRUK/YCR Sheffield Cancer Research Centre, Department of Oncology, University of Sheffield, Sheffield, United Kingdom.
Shah M; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, United Kingdom.
Jakubowska A; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland.
Lubinski J; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland.
Jaworska-Bieniek K; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland; Postgraduate School of Molecular Medicine, Warsaw Medical University, Warsaw, Poland.
Durda K; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland.
Swerdlow A; Division of Genetics and Epidemiology and Division of Breast Cancer Research, The Institute of Cancer Research, Sutton, Surrey, United Kingdom.
Ashworth A; Breakthrough Breast Cancer Research Centre, Division of Breast Cancer Research, The Institute of Cancer Research, London, United Kingdom.
Orr N; Breakthrough Breast Cancer Research Centre, Division of Breast Cancer Research, The Institute of Cancer Research, London, United Kingdom.
Schoemaker M; Division of Genetics and Epidemiology, Institute of Cancer Research, London, United Kingdom.
Couch FJ; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, United States of America.
Hallberg E; Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota, United States of America.
González-Neira A; Human Genotyping-CEGEN Unit, Human Cancer Genetics Program, Spanish National Cancer Research Centre [CNIO], Madrid, Spain.
Pita G; Human Genotyping-CEGEN Unit, Human Cancer Genetics Program, Spanish National Cancer Research Centre [CNIO], Madrid, Spain.
Alonso MR; Human Genotyping-CEGEN Unit, Human Cancer Genetics Program, Spanish National Cancer Research Centre [CNIO], Madrid, Spain.
Tessier DC; McGill University and Génome Québec Innovation Centre, Montréal, Québec, Canada.
Vincent D; McGill University and Génome Québec Innovation Centre, Montréal, Québec, Canada.
Bacot F; McGill University and Génome Québec Innovation Centre, Montréal, Québec, Canada.
Bolla MK; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom.
Wang Q; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom.
Dennis J; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom.
Michailidou K; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom.
Dunning AM; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, United Kingdom.
Hall P; Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
Easton D; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom.
Pharoah P; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, United Kingdom; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom.
Schmidt MK; Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.
Tomlinson I; Wellcome Trust Centre for Human Genetics and Oxford Biomedical Research Centre, University of Oxford, Oxford, United Kingdom.
Garcia-Closas M; Division of Genetics and Epidemiology, Institute of Cancer Research, London, United Kingdom; Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, United Kingdom.; Pokaż więcej
Corporate Authors:: GENICA Network
KConFab Investigators; Peter MacCallum Cancer Center, Melbourne, Australia.
Źródło:: PLoS genetics [PLoS Genet] 2014 Apr 17; Vol. 10 (4), pp. e1004285. Date of Electronic Publication: 2014 Apr 17 (Print Publication: 2014).
Typ publikacji:: Journal Article; Meta-Analysis; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
MeSH Terms:: Breast Neoplasms/*genetics
Carcinoma in Situ/*genetics
Carcinoma, Lobular/*genetics
Genetic Predisposition to Disease/*genetics
Case-Control Studies ; Female ; Genome-Wide Association Study ; Genotype ; Humans ; Middle Aged ; Polymorphism, Single Nucleotide/genetics